Building your credibility and getting past the introductory meeting are the two goals biotech companies going to BIO should keep in mind, according to US-based biotech communications specialist Doug MacDougall.

China has the potential to be a lucrative market for biotechnology, with opportunities in biopharmaceuticals, agricultural biotechnology and industrial biotechnology applications, according to speakers at this morning's BioMelbourne Network breakfast.

The competition between Victoria, NSW and Queensland over which state has the best biotechnology industry appears to have been resolved today with an agreement to form the Australian Biotech Alliance.

Australian sleep apnoea devices manufacturer ResMed has taken out the 2002 NSW Premier's Exporter of the Year Award as well as the award for the 2002 NSW Exporter of the Year in the Large Advanced Manufacturer category, which is for manufacturers with more than $20 million in annual sales.